157 related articles for article (PubMed ID: 2013850)
1. Limits on optimizing ocular drug delivery.
Keister JC; Cooper ER; Missel PJ; Lang JC; Hager DF
J Pharm Sci; 1991 Jan; 80(1):50-3. PubMed ID: 2013850
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
3. Vesicular systems in ocular drug delivery: an overview.
Kaur IP; Garg A; Singla AK; Aggarwal D
Int J Pharm; 2004 Jan; 269(1):1-14. PubMed ID: 14698571
[TBL] [Abstract][Full Text] [Related]
4. [Transcorneal drug delivery: prospects for the use of liposomes].
Aliautdin RN; Iezhitsa IN; Agarval R
Vestn Oftalmol; 2014; 130(4):117-22. PubMed ID: 25306734
[TBL] [Abstract][Full Text] [Related]
5. Transient analysis of ocular drug delivery: zero-volume effect.
Keister JC; Heidmann PS; Missel PJ
J Pharm Sci; 1997 Sep; 86(9):1040-5. PubMed ID: 9294819
[TBL] [Abstract][Full Text] [Related]
6. Liposomes in topical ophthalmic drug delivery: an update.
Agarwal R; Iezhitsa I; Agarwal P; Abdul Nasir NA; Razali N; Alyautdin R; Ismail NM
Drug Deliv; 2016 May; 23(4):1075-91. PubMed ID: 25116511
[TBL] [Abstract][Full Text] [Related]
7. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
[TBL] [Abstract][Full Text] [Related]
8. Corneal penetration and ocular bioavailability of drugs.
Burstein NL; Anderson JA
J Ocul Pharmacol; 1985; 1(3):309-26. PubMed ID: 3916851
[TBL] [Abstract][Full Text] [Related]
9. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models.
Choi KE; Song JS; Kang B; Eom Y; Kim HM
Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
11. [Biological availability of ophthalmic drugs. 1. Increasing drug permeability in the cornea].
Masteiková R; Chalupová Z; Savickiene N
Ceska Slov Farm; 2004 Mar; 53(2):73-9. PubMed ID: 15095575
[TBL] [Abstract][Full Text] [Related]
12. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
13. A corneal perfusion device for estimating ocular bioavailability in vitro.
Richman JB; Tang-Liu DD
J Pharm Sci; 1990 Feb; 79(2):153-7. PubMed ID: 2324964
[TBL] [Abstract][Full Text] [Related]
14. Permeability of the cornea to topically applied drugs.
Benson H
Arch Ophthalmol; 1974 Apr; 91(4):313-27. PubMed ID: 4621283
[No Abstract] [Full Text] [Related]
15. Theoretical corneal permeation model for ionizable drugs.
Friedrich SW; Cheng YL; Saville BA
J Ocul Pharmacol; 1993; 9(3):229-49. PubMed ID: 8228531
[TBL] [Abstract][Full Text] [Related]
16. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
Zhang J; Wang L; Gao C; Zhang L; Xia H
J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
[TBL] [Abstract][Full Text] [Related]
17. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
[TBL] [Abstract][Full Text] [Related]
18. Corneal and conjunctival drug permeability: Systematic comparison and pharmacokinetic impact in the eye.
Ramsay E; Del Amo EM; Toropainen E; Tengvall-Unadike U; Ranta VP; Urtti A; Ruponen M
Eur J Pharm Sci; 2018 Jul; 119():83-89. PubMed ID: 29625211
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutical considerations in topical ocular drug delivery.
Davies NM
Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):558-62. PubMed ID: 10874518
[TBL] [Abstract][Full Text] [Related]
20. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.
Lanier OL; Manfre MG; Bailey C; Liu Z; Sparks Z; Kulkarni S; Chauhan A
AAPS PharmSciTech; 2021 Mar; 22(3):107. PubMed ID: 33719019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
